Comment on: The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

Vaccine

Volumn 29, Issue 21, 2011, Pages 3731-

  Campbell, David Ian ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE; VACCINE;

COST EFFECTIVENESS ANALYSIS; EUROPE; HEALTH SERVICE; HOSPITAL INFECTION; LETTER; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; ROTAVIRUS; VACCINATION;

COST-BENEFIT ANALYSIS; CROSS INFECTION; EUROPE; GASTROINTESTINAL DISEASES; HUMANS; PATIENT READMISSION; PUBLIC HEALTH; RESPIRATORY TRACT INFECTIONS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 79955080861     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.022     Document Type: Letter

References (3)

1. Jit M., Bilcke J., Mangen M.J., Salo H., Melliez H., Edmunds W.J., et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe. Vaccine 2009, 27(44):6121-6128.
2. Gleizes O., Desselberger U., Tatochenko V., Rodrigo C., Salman N., Mezner Z., et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatric Infectious Disease Journal 2006, 25(1):S12-S21.
3. Jit M., Edmunds W.J. Evaluating rotavirus vaccination in England and Wales. Part II: The potential cost-effectiveness of vaccination. Vaccine 2007, 25:3971-3979.